Jim has 25 years of nonclinical drug safety research and development experience that included tactical and strategic support of nonclinical development projects and successive managerial appointments. Jim has significant experience in the regulatory toxicology field (US, EU, and Japan), and has contributed to over 100 IND and NDA submissions including, during his time at Pfizer/Warner-Lambert, those for Lipitor, Neurontin, and Lyrica.

Steve has over 25 years of toxicology experience, including key roles as a drug development team representative for multiple therapeutic areas, and developing and implementing experimental and regulatory strategies to support development of promising preclinical drug candidates. Prior to cofounding INDS in 2007, Steve was an Associate Research Fellow in Drug Safety Research &Development, Pfizer Global Research and Development in Ann Arbor, MI.

Joyce, a certified project manager (PMP), has over 20 years of experience in drug safety, focused on data analysis and visualization, data warehousing, report automation, resource analysis, and business modeling. Prior to cofounding INDS, Joyce was Director of Business & Project Management, Site Operations Lead, and then Global Performance Excellence site lead in the Drug Safety department at Pfizer Global Research & Development in Ann Arbor, MI.

A founding partner of INDS, Marc previously led the Safety Pharmacology Group at Pfizer, Ann Arbor, and has served as a safety pharmacology expert within and outside of Pfizer. Marc was a key member of numerous Discovery and Development project teams and he has extensive experience evaluating the pharmacologic and toxicologic activity of drug candidates. Marc also contributed to the first filing of a novel Exploratory IND paradigm with the FDA.